IMCR
Immunocore·NASDAQ
--
--(--)
--
--(--)
IMCR fundamentals
Immunocore (IMCR) released its earnings on Aug 7, 2025: revenue was 98.00M (YoY +29.97%), beat estimates; EPS was -0.2 (YoY +13.04%), missed estimates.
Revenue / YoY
98.00M
+29.97%
EPS / YoY
-0.2
+13.04%
Report date
Aug 7, 2025
IMCR Earnings Call Summary for Q2,2025
- Revenue Growth: Q2 2025 KIMMTRAK sales of $98 million (+30% YoY), with U.S. up 15% and Europe up 115%.
- Pipeline Momentum: Phase III trials (TEBE-AM, ATOM, PRISM-MEL) advancing; type 1 diabetes CTA expected by year-end 2025.
- Financial Strength: $883 million cash balance; net loss narrowed to $5 million (vs. $36 million in Q2 2024).
- Strategic Expansion: 28-country launch, 68% U.S. community prescriptions, and 13-month duration of therapy.
- Innovation Focus: Autoimmune programs and HIV viral control trials set to enter clinical testing in 2026.
EPS
Revenue
Revenue & Expenses
IMCR has released its 2025 Q3 earnings report, with revenue of 103.69M, reflecting a YoY change of 29.22%, and net profit of -177.00K, showing a YoY change of -102.03%. The Sankey diagram below clearly presents IMCR's revenue sources and cost distribution.
Key Indicators
Immunocore (IMCR) key financial stats and ratios, covering profitability, financial health, and leverage.
Immunocore (IMCR)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Immunocore (IMCR)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Immunocore (IMCR)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Immunocore (IMCR) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Immunocore (IMCR) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is Immunocore's gross profit margin?What does Immunocore do and what are its main business segments?What guidance did Immunocore's management provide for the next earnings period?What is the market's earnings forecast for Immunocore next quarter?What is the revenue and EPS growth rate for Immunocore year over year?What were the key takeaways from Immunocore’s earnings call?Did Immunocore beat or miss consensus estimates last quarter?What is Immunocore's latest dividend and current dividend yield?
